ICU Medical Inc
NASDAQ:ICUI
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
86.88
183.83
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
ICU Medical Inc
Wall Street
Price Targets
ICUI Price Targets Summary
ICU Medical Inc
According to Wall Street analysts, the average 1-year price target for
ICUI
is 213.95 USD
with a low forecast of 202 USD and a high forecast of 236.25 USD.
ICUI Last Price Targets
ICU Medical Inc
The latest public price target was made on Oct 15, 2024 by
Brett Fishbin
from
KeyBanc
,
who expects
ICUI
stock to
rise by 20%
over the next 12 months.
You can read more about this price target by viewing
the article on TheFly.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
Brett Fishbin
KeyBanc
|
198
USD
Upside 20% |
2 months ago
Oct 15, 2024
|
ICU Medical price target raised to $198 from $147 at KeyBanc
TheFly
|
Michael Toomey
Jefferies
|
183
USD
Upside 11% |
2 months ago
Oct 14, 2024
|
Jefferies Starts ICU Medical (ICUI) at Hold
StreetInsider
|
Jayson Bedford
Raymond James
|
135
USD
Downside 18% |
6 months ago
Jun 17, 2024
|
Raymond James Upgrades ICU Medical (ICUI) to Outperform
StreetInsider
|
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is ICUI's stock price target?
Price Target
213.95
USD
According to Wall Street analysts, the average 1-year price target for
ICUI
is 213.95 USD
with a low forecast of 202 USD and a high forecast of 236.25 USD.
What is ICU Medical Inc's Revenue forecast?
Projected CAGR
1%
For the last 8 years the
compound annual growth rate for
ICU Medical Inc's revenue is
27%.
The projected
CAGR
for the next 4 years is
1%.
What is ICU Medical Inc's Operating Income forecast?
Projected CAGR
75%
For the last 8 years the
compound annual growth rate for
ICU Medical Inc's operating income is
-3%.
The projected
CAGR
for the next 3 years is
75%.
You don't have any saved screeners yet
